Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kejin Wu

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Plos One|August 5, 2014
Oxygen-carbon nanotubes as a chemotherapy sensitizer for paclitaxel in breast cancer treatmentYongkun Wang, Chuanying Wang, Yijun Jia, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2003
Stage-specific expression of breast cancer-specific gene gamma-synucleinKejin Wu, Ziyi Weng, Qinghua Tao, et al.
Frontiers in Immunology|December 26, 2022
FOXP3+ regulatory T cells and the immune escape in solid tumoursYiran Qiu, Shouyu Ke, Jieqiong Chen, et al.
Breast Cancer Research and Treatment|July 6, 2006
Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosisKejin Wu, Zhiwei Quan, Ziyi Weng, et al.
Cancer Cell International|February 26, 2021
Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancerJihui Chen, Zhipeng Wang, Shouhong Gao, et al.
Medical Oncology (Northwood, London, England)|May 23, 2013
Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancerKejin Wu, Shuo Huang, Mingjie Zhu, et al.
Breast Cancer Research and Treatment|December 3, 2013
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancerXiaosong Chen, Guolin Ye, Chenfang Zhang, et al.
FEBS Letters|May 26, 2017
DNMT1 cooperates with MBD4 to inhibit the expression of Glucocorticoid-induced TNFR-related protein in human T cellsShuaiwei Wang, Yangyang Li, Fangming Zhu, et al.
Frontiers in Oncology|March 21, 2022
An Innovative Breast-Conserving Oncoplastic Technique for Treating Small to Medium Volume Breasts With a Tumor in the Lower Quadrant: The Folding Flap TechniqueWenjie Shi, Maoli Wang, Luz Angela Torres-de la Roche, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 24, 2024
LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradationZhiyuan Jiang, Qianru Huang, Yujie Chang, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Plos One|August 5, 2014
Oxygen-carbon nanotubes as a chemotherapy sensitizer for paclitaxel in breast cancer treatmentYongkun Wang, Chuanying Wang, Yijun Jia, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2003
Stage-specific expression of breast cancer-specific gene gamma-synucleinKejin Wu, Ziyi Weng, Qinghua Tao, et al.
Frontiers in Immunology|December 26, 2022
FOXP3+ regulatory T cells and the immune escape in solid tumoursYiran Qiu, Shouyu Ke, Jieqiong Chen, et al.
Breast Cancer Research and Treatment|July 6, 2006
Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosisKejin Wu, Zhiwei Quan, Ziyi Weng, et al.
Cancer Cell International|February 26, 2021
Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancerJihui Chen, Zhipeng Wang, Shouhong Gao, et al.
Medical Oncology (Northwood, London, England)|May 23, 2013
Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancerKejin Wu, Shuo Huang, Mingjie Zhu, et al.
Breast Cancer Research and Treatment|December 3, 2013
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancerXiaosong Chen, Guolin Ye, Chenfang Zhang, et al.
FEBS Letters|May 26, 2017
DNMT1 cooperates with MBD4 to inhibit the expression of Glucocorticoid-induced TNFR-related protein in human T cellsShuaiwei Wang, Yangyang Li, Fangming Zhu, et al.
Frontiers in Oncology|March 21, 2022
An Innovative Breast-Conserving Oncoplastic Technique for Treating Small to Medium Volume Breasts With a Tumor in the Lower Quadrant: The Folding Flap TechniqueWenjie Shi, Maoli Wang, Luz Angela Torres-de la Roche, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 24, 2024
LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradationZhiyuan Jiang, Qianru Huang, Yujie Chang, et al.
Pageof 5